FDA Inspection 1168977 — Isabel Leroux-Roels, M.D, PhD.
The FDA completed an inspection of Isabel Leroux-Roels, M.D, PhD. on Apr 27, 2022 in Gent. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 27, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Gent (Belgium)